Literature DB >> 1715327

Identification of subregions of Bordetella pertussis filamentous hemagglutinin that stimulate human T-cell responses.

A Di Tommaso1, M Domenighini, M Bugnoli, A Tagliabue, R Rappuoli, M T De Magistris.   

Abstract

Filamentous hemagglutinin (FHA), a 220-kDa protein that mediates the adhesion of Bordetella pertussis to eukaryotic cells, is a component of acellular vaccines against whooping cough. To identify the subregions of FHA that are immunogenic for T cells, 16 human T-cell clones were raised against purified FHA and tested for the recognition of recombinant and proteolytic fragments. The clones were found to map either in the carboxy-terminal or the amino-terminal part of the FHA molecule, but none of them recognized the central region, which contains a sequence that is homologous to that of the eukaryotic protein fibronectin. These data suggest that subregions of FHA that do not contain sequences that are potentially cross-reactive with self proteins may be sufficient to induce an immune response against the whole protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1715327      PMCID: PMC258172          DOI: 10.1128/iai.59.9.3313-3315.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Prediction of immunodominant helper T cell antigenic sites from the primary sequence.

Authors:  H Margalit; J L Spouge; J L Cornette; K B Cease; C Delisi; J A Berzofsky
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

2.  Genetic characterization of Bordetella pertussis filamentous haemagglutinin: a protein processed from an unusually large precursor.

Authors:  M Domenighini; D Relman; C Capiau; S Falkow; A Prugnola; V Scarlato; R Rappuoli
Journal:  Mol Microbiol       Date:  1990-05       Impact factor: 3.501

Review 3.  Haemophilus influenzae infections and whooping cough.

Authors:  E R Moxon; R Rappuoli
Journal:  Lancet       Date:  1990-06-02       Impact factor: 79.321

4.  Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence.

Authors:  D A Relman; M Domenighini; E Tuomanen; R Rappuoli; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis.

Authors:  D Relman; E Tuomanen; S Falkow; D T Golenbock; K Saukkonen; S D Wright
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

6.  Expression and immunological properties of the five subunits of pertussis toxin.

Authors:  A Nicosia; A Bartoloni; M Perugini; R Rappuoli
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

7.  Development of a pertussis component vaccine in Japan.

Authors:  Y Sato; M Kimura; H Fukumi
Journal:  Lancet       Date:  1984-01-21       Impact factor: 79.321

Review 8.  Virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett
Journal:  Annu Rev Microbiol       Date:  1986       Impact factor: 15.500

9.  Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.

Authors:  H Sato; Y Sato
Journal:  Dev Biol Stand       Date:  1985

10.  Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.

Authors:  M T De Magistris; M Romano; A Bartoloni; R Rappuoli; A Tagliabue
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  5 in total

1.  Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.

Authors:  J B Knight; Y Y Huang; S A Halperin; R Anderson; A Morris; A Macmillan; T Jones; D S Burt; G Van Nest; S F Lee
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

Review 2.  Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy.

Authors:  Kerrie Vaughan; Emily Seymour; Bjoern Peters; Alessandro Sette
Journal:  Hum Immunol       Date:  2014-02-12       Impact factor: 2.850

3.  Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing.

Authors:  A di Tommaso; M T de Magistris; M Bugnoli; I Marsili; R Rappuoli; S Abrignani
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Subcutaneous vaccination with attenuated Salmonella enterica serovar Choleraesuis C500 expressing recombinant filamentous hemagglutinin and pertactin antigens protects mice against fatal infections with both S. enterica serovar Choleraesuis and Bordetella bronchiseptica.

Authors:  Zhanqin Zhao; Yun Xue; Bin Wu; Xibiao Tang; Ruiming Hu; Yindi Xu; Aizhen Guo; Huanchun Chen
Journal:  Infect Immun       Date:  2008-02-11       Impact factor: 3.441

5.  Expression, Purification and Characterization of Three Overlapping Immunodominant Recombinant Fragments from Bordetella pertussis Filamentous Hemagglutinin.

Authors:  Hossein Asgarian-Omran; Ali Akbar Amirzargar; Mohammad Arjmand; Mohammadreza Eshraghian; Behrooz Nikbin; Saeid Eshraghi; Marzieh Mahdavi; Jalal Khoshnoodi; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Fazel Shokri
Journal:  Avicenna J Med Biotechnol       Date:  2013-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.